Stockreport

Eledon Pharmaceuticals Touts Tegoprubart Safety in BESTOW Kidney Transplant Data at Leerink Conference [Yahoo! Finance]

Eledon Pharmaceuticals, Inc.  (ELDN) 
PDF endpoint (patient survival, organ survival, rejection) versus tacrolimus while showing markedly improved safety — for example, tremor rates ~1–2% vs ~25%, lower delayed [Read more]